Free Trial
OTCMKTS:CVAT

Cavitation Technologies (CVAT) Stock Price, News & Analysis

Cavitation Technologies logo
$0.03 +0.00 (+0.37%)
As of 04/25/2025 03:50 PM Eastern

About Cavitation Technologies Stock (OTCMKTS:CVAT)

Key Stats

Today's Range
$0.03
$0.03
50-Day Range
$0.02
$0.03
52-Week Range
$0.00
$0.03
Volume
668,560 shs
Average Volume
279,198 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in the processing of various industrial and consumer-oriented fluids in the United States. It provides Nano Reactor and Nano Neutralization Systems for refining vegetable oils, such as soybean, rapeseed, canola, and palm oil. The company also develops technology-based systems for various markets, including renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions, and crude oil yield enhancement, as well as small home appliances. Cavitation Technologies, Inc. was founded in 2007 and is headquartered in Chatsworth, California.

Cavitation Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
7th Percentile Overall Score

CVAT MarketRank™: 

Cavitation Technologies scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Cavitation Technologies.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cavitation Technologies is -1.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cavitation Technologies is -1.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Cavitation Technologies has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cavitation Technologies has recently increased by 426.41%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cavitation Technologies does not currently pay a dividend.

  • Dividend Growth

    Cavitation Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Cavitation Technologies has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cavitation Technologies has recently increased by 426.41%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Cavitation Technologies has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Industrials companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Cavitation Technologies this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Cavitation Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    28.11% of the stock of Cavitation Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 8.53% of the stock of Cavitation Technologies is held by institutions.

  • Read more about Cavitation Technologies' insider trading history.
Receive CVAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cavitation Technologies and its competitors with MarketBeat's FREE daily newsletter.

CVAT Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
CTI Welcomes a New Member to the Advisory Board
EQS-News: CTI Welcomes a New Member to the Advisory Board
See More Headlines

CVAT Stock Analysis - Frequently Asked Questions

Cavitation Technologies' stock was trading at $0.0189 at the start of the year. Since then, CVAT shares have increased by 43.4% and is now trading at $0.0271.
View the best growth stocks for 2025 here
.

Shares of CVAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cavitation Technologies investors own include Adamis Pharmaceuticals (ADMP), Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Altimmune (ALT) and Digital Ally (DGLY).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Specialty Industrial Machinery
Sub-Industry
Agriculture
Current Symbol
OTCMKTS:CVAT
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:CVAT) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners